Human Investing’s Elevance Health ELV Stock Holding History

Human Investing’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-253	Closed	-$91K	–	164
2021 Q1	$91K	Hold	253	–	–	0.02%	138
2020 Q4	$81K	Sell	253 -50	-17%	-$15.3K	0.02%	150
2020 Q3	$81K	Hold	303	–	–	0.03%	136
2020 Q2	$80K	Hold	303	–	–	0.03%	138
2020 Q1	$69K	Hold	303	–	–	0.03%	137
2019 Q4	$92K	Hold	303	–	–	0.03%	160
2019 Q3	$73K	Hold	303	–	–	0.03%	181
2019 Q2	$86K	Hold	303	–	–	0.03%	168
2019 Q1	$87K	Hold	303	–	–	0.03%	159
2018 Q4	$80K	Buy	+303	New	+$83.3K	0.03%	175

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Human Investing's ELV Position: Q2 2021 in Review

Human Investing sold out of Elevance Health (ELV) in Q2 2021, closing a stake of 253 shares — an estimated $91K sold.

Human Investing first reported a position in ELV in Q4 2018 and held it in 10 quarters. The position peaked at $92K in Q4 2019. 1,234 funds tracked by Wall St. Rank hold ELV as of Q2 2021.

Human Investing reported no remaining Elevance Health position as of Q2 2021 after selling out during the quarter.
Human Investing sold 253 Elevance Health shares in Q2 2021, an estimated $91K.
Human Investing first reported a position in Elevance Health in Q4 2018 and held it in 10 quarters.
Human Investing's Elevance Health position peaked at $92K in Q4 2019.
1,234 funds tracked by Wall St. Rank held Elevance Health as of Q2 2021.

Based on Human Investing's 13F filing for Q2 2021, filed 2 Aug 2021.